Respiratory Virus Metagenomics After COVID-19
Metagenomic Study on the Distributive Pattern of Respiratory Virus in the Community After the Emergence of COVID-19
Metagenomic Study on the Distributive Pattern of Respiratory Virus in the Community After the Emergence of COVID-19
Sponsor study identifier
observational
500
1 country
1
Study Start
December 28, 2021
Actual (reported)Primary Completion
July 31, 2026
Actual (reported)Study Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The study aims to characterize the distributive pattern of viruses in upper airway and its relationship with influenza seasons, symptomatology and exposure setting. A total of 500 adults residing in Hong Kong would be recruited, who would complete a questionnaire and return self-collected nasal and throat swabs for metagenomic analyses.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 17, 2021
Actual (reported)November 19, 2021
Actual (reported)December 28, 2021
Actual (reported)July 31, 2026
Actual (reported)January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Positive identification of viruses
Proportion of specimens with identified respiratory virus taxa
4 years
Subjects would be invited by post through randomly selected households throughout the territory of Hong Kong.
Prince of Wales Hospital
Hong Kong, Hong Kong, China
nasal and throat swabs
Shui Shan Lee
Chinese University of Hong Kong
First Submitted
November 17, 2021
First Posted
November 19, 2021
Study Start
December 28, 2021
Actual (reported)Primary Completion
July 31, 2026
Actual (reported)Evaluation of Dynamic Balance After Recovery From COVID 19 Disease
Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients
Evaluation of Home Use COVID-19 Frequent Antigen Testing and Data Reporting
Contact the study team to confirm eligibility.
Study Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 21, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: